Novartis Investigative Site — Washington D.C., District of Columbia

Novartis Investigative Site is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Novartis Investigative Site has participated in 31 clinical trials with 1 currently active.

Therapeutic areas: Relapsing Multiple Sclerosis, Metastases, Brain, Liver Transplantation.

Sponsors: Novartis Pharmaceuticals, Novartis.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Investigative Site?

Novartis Investigative Site has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Investigative Site conducted?

Novartis Investigative Site has 31 clinical trials on record, with 1 currently active. Their work covers Relapsing Multiple Sclerosis, Metastases, Brain, Liver Transplantation.

Is Novartis Investigative Site accredited by Crixeo Health?

Yes — Novartis Investigative Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Novartis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.